Pharma & Biotechtargeted molecular optimizationreal case study deployment

Digital chemistry design of an orally bioavailable α4β7 integrin inhibitor with Morphic Therapeutic

A biotech company used Schrödinger’s digital chemistry tools and experts to help design a pill-like drug aimed at a specific disease target.

9.5
Quality
Score

Executive Brief

Business Problem Solved

Premium content - unlock to see the business problem analysis...

Value Drivers

Value Driver 1Value Driver 2

Strategic Moat

Premium content - unlock to see strategic analysis...

Premium Access

Full Analysis Available

Executive brief, technical architecture, and market positioning for this use case.

Pharmaceuticalsbiotech — $499/yrAtlas Pro — $1,499/yr
Executive Brief•Technical•Market Signal

Technical Analysis

Model Strategy

Premium content...

Data Strategy

Premium content...

Implementation Complexity

Premium content...

Scalability Bottleneck

Premium content...

Premium Access

Full Analysis Available

Executive brief, technical architecture, and market positioning for this use case.

Pharmaceuticalsbiotech — $499/yrAtlas Pro — $1,499/yr
Executive Brief•Technical•Market Signal

Market Signal

Adoption Stage

Premium content...

Differentiation Factor

Premium content...

Key Competitors

Company ACompany B
Premium Access

Full Analysis Available

Executive brief, technical architecture, and market positioning for this use case.

Pharmaceuticalsbiotech — $499/yrAtlas Pro — $1,499/yr
Executive Brief•Technical•Market Signal

Part of Application

Oral Integrin Target Designer

1 use cases in this application

Explore More

More in Pharma & Biotech→More targeted molecular optimization→

Source

https://schrodinger.com/life-science/use-cases/biotech-and-pharmaceuticals